Thrivent Financial for Lutherans Trims Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Thrivent Financial for Lutherans lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 444,800 shares of the exchange traded fund’s stock after selling 68,786 shares during the period. Thrivent Financial for Lutherans owned 0.58% of SPDR S&P Biotech ETF worth $40,059,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in XBI. Howard Capital Management Group LLC grew its holdings in shares of SPDR S&P Biotech ETF by 2.6% during the 3rd quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after acquiring an additional 6,188 shares during the period. Howe & Rusling Inc. purchased a new stake in SPDR S&P Biotech ETF in the third quarter worth $49,000. Biltmore Family Office LLC raised its holdings in SPDR S&P Biotech ETF by 5.6% in the third quarter. Biltmore Family Office LLC now owns 19,156 shares of the exchange traded fund’s stock worth $1,893,000 after purchasing an additional 1,009 shares in the last quarter. Nwam LLC purchased a new position in SPDR S&P Biotech ETF during the third quarter valued at $1,475,000. Finally, Clal Insurance Enterprises Holdings Ltd bought a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at $141,284,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $87.46 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market cap of $5.67 billion, a price-to-earnings ratio of 11.47 and a beta of 0.99. The company has a 50-day moving average of $89.75 and a 200 day moving average of $94.53.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.